Cargando…
Immunotherapy in Elderly Patients Affected by Non-Small Cell Lung Cancer: A Narrative Review
Lung cancer is the leading cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) accounts for approximately 80% of all lung cancers, and most NSCLC is diagnosed in the advanced stage. The advent of immune check point inhibitors (ICIs) changed the therapeutic scenario both in m...
Autores principales: | Montrone, Michele, Rosati, Gerardo, Longo, Vito, Catino, Annamaria, Massafra, Raffaella, Nardone, Annalisa, Pesola, Francesco, Montagna, Elisabetta Sara, Marech, Ilaria, Pizzutilo, Pamela, Galetta, Domenico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003062/ https://www.ncbi.nlm.nih.gov/pubmed/36902620 http://dx.doi.org/10.3390/jcm12051833 |
Ejemplares similares
-
What Are the Biomarkers for Immunotherapy in SCLC?
por: Longo, Vito, et al.
Publicado: (2021) -
Successful treatment of triple EGFR mutation T785A/L861Q/H297_E298 with afatinib
por: Longo, Vito, et al.
Publicado: (2021) -
Prognostic factors for survival in extensive‐stage small cell lung cancer: An Italian real‐world retrospective analysis of 244 patients treated over the last decade
por: Longo, Vito, et al.
Publicado: (2022) -
Esophageal Stricture Caused by ALK-Positive NSCLC Esophageal Metastasis Resolved After a Few Days of Lorlatinib Therapy Without Stent Placement
por: Longo, Vito, et al.
Publicado: (2020) -
Gender Differences and Immunotherapy Outcome in Advanced Lung Cancer
por: Vavalà, Tiziana, et al.
Publicado: (2021)